We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Novel Implant Coating Material Releases Antibiotics in Response to Bacterial Invasion

By HospiMedica International staff writers
Posted on 05 Mar 2024
Print article
Image: Schematic depicting the implantation healing process (Photo courtesy of POSTECH)
Image: Schematic depicting the implantation healing process (Photo courtesy of POSTECH)

Artificial joints, often used to treat degenerative arthritis, create the challenge of bacterial infections. These infections can undermine the stability of the implant and lead to various complications, including those caused by antibiotic-resistant bacteria. These bacteria often trigger recurring infections even after antibiotic treatment, necessitating further procedures. Now, researchers have designed a functional implant coating material that promptly releases antibiotics in reaction to changes in the body's environment as a result of bacterial infection.

Developed by a collaborative research team comprising scientists from Pohang University of Science and Technology (POSTECH, Gyeongbuk, Korea), the coating is based on mussel adhesion proteins. Their research specifically focused on DOPA, an amino acid key to mussel adhesion. DOPA forms strong bonds with metal ions, particularly iron, but these bonds weaken when the acidity (pH) level drops. Given that bacterial invasion alters the body's pH, the team designed the coating that contains antibiotics under normal conditions, but releases them rapidly when infection-induced acidification occurs. It releases 70% of the antibiotics within eight hours, effectively eliminating the bacteria.

The material also exhibits remarkable durability, maintaining its antibacterial efficacy even during the four weeks of bone regeneration phase following an implant procedure. The amount of antibiotics released by the material matches the severity of the bacterial infection. The researchers validated the antibacterial efficacy of the coating material based on varying bacterial concentrations. Importantly, the bond between DOPA and iron ions proved highly resistant to external physical stimuli, making it resistant to abrasion and mechanical loads during the implantation process.

"The immediate and sustained antimicrobial effect of the adhesive implant coating material has the potential to significantly enhance the success rate of implant procedures," said Professor Hyung Joon Cha from POSTECH who led the study.

Related Links:
POSTECH

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
24.5-inch Full HD 2D OLED Medical Monitor
PVM-2551MD

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.